Dane Andreeff - 30 Nov 2023 Form 4/A Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Dane Andreeff
Issuer symbol: HSDT
Transactions as of: 30 Nov 2023
Net transactions value: +$8,229
Form type: 4/A
Filing time: 15 Feb 2024, 16:06:00 UTC
Date Of Original Report: 04 Dec 2023
Previous filing: 30 Aug 2023
Next filing: 15 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HSDT	Common Stock	Purchase	$4,083	+641	+107%	$6.37	1,239	30 Nov 2023	See footnote	F1, F2, F3
transaction	HSDT	Common Stock	Purchase	$4,146	+643	+52%	$6.45	1,882	01 Dec 2023	See footnote	F1, F2, F3
holding	HSDT	Common Stock						9,991	30 Nov 2023	See footnote	F1, F2, F4
holding	HSDT	Common Stock						13,684	30 Nov 2023	See footnote	F2, F5
holding	HSDT	Common Stock						29	30 Nov 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 4, 2023, the reporting person filed a Form 4 (the "Original Form 4") which incorrectly reported that these shares were purchased by Maple Leaf Discovery I, LP ("MLD I"), when in fact they were purchased by Maple Leaf Offshore, Ltd. ("MLO"). This amendment is being filed to correctly reflect the purchases and the amount of shares held by both MLD I and MLO following the reported transactions.
F2	As a result of a rounding error following a reverse stock split by the Issuer, the Original Form 4 incorrectly stated the amount of securities beneficially owned. The amounts reported on this amendment have been corrected to reflect the actual number of shares held at the time of filing the Original Form 4.
F3	The shares are held by MLO. The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F4	The shares are held by MLD I. The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F5	The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.